3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
5
Neoplasms
3
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Supratentorial Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Postoperative Complications
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Ovarian Cysts
1
Myofibroma
1
Lung Neoplasms
1
Liver Neoplasms
1
Hematologic Diseases
1
Endobronchial Metastases
1
Encephalocele
1
Ear Neoplasms
1
Cholecystitis
1
Breast Neoplasms
1
Brain Injuries
1
Interventions
Radiotherapy
4
ferric carboxymaltose
3
Exercise
3
Surgical Procedures, Operative
2
Standard of Care
2
Sodium Chloride
2
Sevoflurane
2
Ropivacaine
2
Propofol
2
Preoperative Exercise
2
Oxaliplatin
2
Immunonutrition Diet
2
Fluorouracil
2
Fibrin Tissue Adhesive
2
Ethanol
2
Dexamethasone
2
Counseling
2
Bevacizumab
2
vapreotide
1
streptococcal preparation 722
1
methyl N-acetylsibirosaminide
1
ferrous sulfate
1
Wound Closure Techniques
1
World Health Organization oral rehydration solution
1
Warm Ischemia
1
Vitamin D
1
Videotape Recording
1
Video-Assisted Surgery
1
Tranexamic Acid
1
Tracheostomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Postoperative Complications
×
Remifentanil
×
Clear all
NCT00555984
2017-04-20
TIVA
The Cleveland Clinic
Phase NA
Withdrawn